The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis

Título:

The in vivo activity of 1,3,4-thiadiazolium-2-aminide compounds in the treatment of cutaneous and visceral leishmaniasis

Autor:

Veronica Figueiredo do Amaral

Ano:

2011

DOI:

10.1093/jac/dkr409

Revista:

Journal of Antimicrobial Chemotherapy (Online)

ISSN:

14602091

Home:

[doi:10.1093/jac/dkr409]

Idioma:

Inglês

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

Anti-Leishmania amazonensis activity of the terpenoid fraction from Eugenia pruniformis leaves

Mixed antigen ELISA of Mycoplasma pulmonisand M. arthritidis for diagnosis of murine mycoplasmosis

Leishmania amazonensis infection induces behavioral alterations and modulates cytokine and neurotrophin production in the murine cerebral cortex

Anti-leishmanial activity of Brazilian green, brown, and red algae

Synthesis and in vitro Evaluation of New Benzenesulfonamides as Antileishmanial Agents

The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives

4-(1H-Pyrazol-1-yl) Benzenesulfonamide Derivatives: Identifying New Active Antileishmanial Structures for Use against a Neglected Disease

Synthesis and antileishmanial evaluation of 1-aryl-4-(4,5-dihydro-1H-imidazol-2-yl)-1H-pyrazole derivatives

Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis

EFFECT OF THE ORAL TREATMENT WITH PYRAZOLE CARBOHYDRAZIDES DERIVATIVES IN THE MURINE INFECTION BY LEISHMANIA AMAZONENSIS